Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 29, 2002
Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients
C W Ahn, H S Kim, J H Nam, et al.
Acta Diabetologica
|
February 6, 2002
Mutation in hepatocyte nuclear factor-1alpha is not a common cause of MODY and early-onset type 2 diabetes in Korea
H J Lee, C W Ahn, S J Kim, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1995
Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans
S K Lim, Y S Park, J M Park, et al.
Diabetes Research and Clinical Practice
|
January 7, 2000
Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy
Y S Yun, H C Lee, N C Yoo, et al.
Yonsei Medical Journal
|
April 13, 1999
The validity of random urine specimen albumin measurement as a screening test for diabetic nephropathy
C W Ahn, Y D Song, J H Kim, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
May 1, 1997
Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone
S Y Nam, E J Lee, K R Kim, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1995
Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects
E J Lee, S Y Nam, K R Kim, et al.
Metabolism: Clinical and Experimental
|
November 1, 1995
Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidism
E J Lee, K R Kim, H C Lee, et al.
Diabetes Research and Clinical Practice
|
February 14, 2002
(AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus
H K Park, C W Ahn, G T Lee, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery
|
August 3, 2021
[Frequency characteristics of horizontal semicircular canals damage and the ultrastructure analysis of crista ampullaris in patients with Meniere's disease]
X F Liu, D G Zhang, Y F Lyu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 29, 2002
Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients
C W Ahn, H S Kim, J H Nam, et al.
Acta Diabetologica
|
February 6, 2002
Mutation in hepatocyte nuclear factor-1alpha is not a common cause of MODY and early-onset type 2 diabetes in Korea
H J Lee, C W Ahn, S J Kim, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1995
Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans
S K Lim, Y S Park, J M Park, et al.
Diabetes Research and Clinical Practice
|
January 7, 2000
Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy
Y S Yun, H C Lee, N C Yoo, et al.
Yonsei Medical Journal
|
April 13, 1999
The validity of random urine specimen albumin measurement as a screening test for diabetic nephropathy
C W Ahn, Y D Song, J H Kim, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
May 1, 1997
Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone
S Y Nam, E J Lee, K R Kim, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1995
Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects
E J Lee, S Y Nam, K R Kim, et al.
Metabolism: Clinical and Experimental
|
November 1, 1995
Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidism
E J Lee, K R Kim, H C Lee, et al.
Diabetes Research and Clinical Practice
|
February 14, 2002
(AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus
H K Park, C W Ahn, G T Lee, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery
|
August 3, 2021
[Frequency characteristics of horizontal semicircular canals damage and the ultrastructure analysis of crista ampullaris in patients with Meniere's disease]
X F Liu, D G Zhang, Y F Lyu, et al.
Page
of 4